Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $85.37 +3.18%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.36), $0.16 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $75.23 million versus the consensus estimate of $52.66 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Citi reiterates Buy rating on Baidu with $166 price target, Opens 30 Day Upside Catalyst Watch
- Netskope, Inc. (NTSK) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
